Chicago Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.16M | Sell |
48,093
-27,402
| -36% | -$717K | 0.03% | 184 |
|
|
2026
Q1 | $2.12M | Sell |
75,495
-36,125
| -32% | -$962K | 0.06% | 131 |
|
|
2025
Q4 | $2.78M | Buy |
111,620
+1,227
| +1% | +$30.9K | 0.07% | 122 |
|
|
2025
Q3 | $2.81M | Buy |
110,393
+2,317
| +2% | +$57.2K | 0.07% | 115 |
|
|
2025
Q2 | $2.62M | Buy |
108,076
+10,701
| +11% | +$250K | 0.06% | 121 |
|
|
2025
Q1 | $2.47M | Buy |
97,375
+27,206
| +39% | +$712K | 0.07% | 115 |
|
|
2024
Q4 | $1.86M | Sell |
70,169
-5,726
| -8% | -$155K | 0.05% | 126 |
|
|
2024
Q3 | $2.2M | Buy |
75,895
+698
| +0.9% | +$20.4K | 0.06% | 116 |
|
|
2024
Q2 | $2.1M | Buy |
75,197
+2,575
| +4% | +$70.9K | 0.06% | 116 |
|
|
2024
Q1 | $2.02M | Sell |
72,622
-3,084
| -4% | -$85.6K | 0.06% | 119 |
|
|
2023
Q4 | $2.18M | Sell |
75,706
-5,607
| -7% | -$169K | 0.08% | 111 |
|
|
2023
Q3 | $2.7M | Sell |
81,313
-396
| -0.5% | -$14K | 0.13% | 68 |
|
|
2023
Q2 | $3M | Buy |
81,709
+105
| +0.1% | +$4.09K | 0.14% | 63 |
|
|
2023
Q1 | $3.33M | Buy |
81,604
+198
| +0.2% | +$8.55K | 0.17% | 64 |
|
|
2022
Q4 | $4.17M | Sell |
81,406
-360
| -0.4% | -$17.3K | 0.23% | 62 |
|
|
2022
Q3 | $3.58M | Buy |
81,766
+60
| +0.1% | +$2.92K | 0.21% | 63 |
|
|
2022
Q2 | $4.28M | Buy |
81,706
+2,980
| +4% | +$152K | 0.24% | 62 |
|
|
2022
Q1 | $4.08M | Buy |
78,726
+1,240
| +2% | +$64.3K | 0.18% | 68 |
|
|
2021
Q4 | $4.58M | Buy |
77,486
+168
| +0.2% | +$8.32K | 0.17% | 67 |
|
|
2021
Q3 | $3.33M | Buy |
77,318
+790
| +1% | +$35K | 0.13% | 69 |
|
|
2021
Q2 | $3M | Buy |
76,528
+100
| +0.1% | +$3.89K | 0.12% | 70 |
|
|
2021
Q1 | $2.77M | Buy |
76,428
+825
| +1% | +$29.3K | 0.12% | 72 |
|
|
2020
Q4 | $2.78M | Sell |
75,603
-1,128
| -1% | -$41.4K | 0.12% | 70 |
|
|
2020
Q3 | $2.67M | Sell |
76,731
-4,111
| -5% | -$144K | 0.14% | 71 |
|
|
2020
Q2 | $2.51M | Buy |
80,842
+3,478
| +4% | +$118K | 0.15% | 71 |
|
|
2020
Q1 | $2.4M | Sell |
77,364
-321
| -0.4% | -$10.9K | 0.19% | 64 |
|
|
2019
Q4 | $2.89M | Sell |
77,685
-696
| -0.9% | -$24.8K | 0.18% | 66 |
|
|
2019
Q3 | $2.67M | Hold |
78,381
| – | – | 0.18% | 64 |
|
|
2019
Q2 | $3.22M | Sell |
78,381
-179
| -0.2% | -$7.11K | 0.21% | 64 |
|
|
2019
Q1 | $3.17M | Buy |
78,560
+127
| +0.2% | +$5.09K | 0.22% | 62 |
|
|
2018
Q4 | $3.25M | Buy |
78,433
+11,607
| +17% | +$482K | 0.26% | 60 |
|
|
2018
Q3 | $2.79M | Sell |
66,826
-342
| -0.5% | -$13.2K | 0.19% | 57 |
|
|
2018
Q2 | $2.31M | Buy |
67,168
+8,318
| +14% | +$284K | 0.19% | 64 |
|
|
2018
Q1 | $1.98M | Buy |
+58,850
| New | +$2.02M | 0.26% | 57 |
|
Other funds holding PFE
AIM
SLAM
CWP
Chicago Capital's PFE Position: Q2 2026 in Review
Chicago Capital reduced its Pfizer (PFE) stake by 36% in Q2 2026, selling an estimated $717K and leaving 48,093 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #184.
Chicago Capital first reported a position in PFE in Q1 2018 and has held it in 34 quarters since. The position peaked at $4.58M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Chicago Capital held 48,093 shares of Pfizer worth $1.16M as of Q2 2026.
- Chicago Capital sold 27,402 Pfizer shares in Q2 2026, an estimated $717K.
- Pfizer made up 0.03% of Chicago Capital's portfolio in Q2 2026, its #184 holding.
- Chicago Capital first reported a position in Pfizer in Q1 2018 and has held it in 34 quarters since.
- Chicago Capital's Pfizer position peaked at $4.58M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.